BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 33186184)

  • 21. Positive Impact of Genetic Test on the Management and Outcome of Patients With Paraganglioma and/or Pheochromocytoma.
    Buffet A; Ben Aim L; Leboulleux S; Drui D; Vezzosi D; Libé R; Ajzenberg C; Bernardeschi D; Cariou B; Chabolle F; Chabre O; Darrouzet V; Delemer B; Desailloud R; Goichot B; Esvant A; Offredo L; Herman P; Laboureau S; Lefebvre H; Pierre P; Raingeard I; Reznik Y; Sadoul JL; Hadoux J; Tabarin A; Tauveron I; Zenaty D; Favier J; Bertherat J; Baudin E; Amar L; Gimenez-Roqueplo AP;
    J Clin Endocrinol Metab; 2019 Apr; 104(4):1109-1118. PubMed ID: 30698717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PHEOCHROMOCYTOMA: A GENETIC AND DIAGNOSTIC UPDATE.
    Mercado-Asis LB; Wolf KI; Jochmanova I; Taïeb D
    Endocr Pract; 2018 Jan; 24(1):78-90. PubMed ID: 29144820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metastatic pheochromocytoma and paraganglioma.
    Angelousi A; Kassi E; Zografos G; Kaltsas G
    Eur J Clin Invest; 2015 Sep; 45(9):986-97. PubMed ID: 26183460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Germline Mutations in the Mitochondrial 2-Oxoglutarate/Malate Carrier
    Buffet A; Morin A; Castro-Vega LJ; Habarou F; Lussey-Lepoutre C; Letouzé E; Lefebvre H; Guilhem I; Haissaguerre M; Raingeard I; Padilla-Girola M; Tran T; Tchara L; Bertherat J; Amar L; Ottolenghi C; Burnichon N; Gimenez-Roqueplo AP; Favier J
    Cancer Res; 2018 Apr; 78(8):1914-1922. PubMed ID: 29431636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patients.
    Calsina B; Currás-Freixes M; Buffet A; Pons T; Contreras L; Letón R; Comino-Méndez I; Remacha L; Calatayud M; Obispo B; Martin A; Cohen R; Richter S; Balmaña J; Korpershoek E; Rapizzi E; Deutschbein T; Vroonen L; Favier J; de Krijger RR; Fassnacht M; Beuschlein F; Timmers HJ; Eisenhofer G; Mannelli M; Pacak K; Satrústegui J; Rodríguez-Antona C; Amar L; Cascón A; Dölker N; Gimenez-Roqueplo AP; Robledo M
    Genet Med; 2018 Dec; 20(12):1652-1662. PubMed ID: 30008476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of the genotype of paragangliomas and pheochromocytomas with their metabolic phenotype on 3,4-dihydroxy-6-18F-fluoro-L-phenylalanin PET.
    Rischke HC; Benz MR; Wild D; Mix M; Dumont RA; Campbell D; Seufert J; Wiech T; Rössler J; Weber WA; Neumann HP
    J Nucl Med; 2012 Sep; 53(9):1352-8. PubMed ID: 22836345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative genetic testing in pheochromocytomas and paragangliomas influences the surgical approach and the extent of adrenal surgery.
    Nockel P; El Lakis M; Gaitanidis A; Yang L; Merkel R; Patel D; Nilubol N; Prodanov T; Pacak K; Kebebew E
    Surgery; 2018 Jan; 163(1):191-196. PubMed ID: 29126554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced uptake pattern on
    de Jong MC; Pinto D; Parameswaran R
    J Surg Oncol; 2023 Oct; 128(5):764-768. PubMed ID: 37403579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. From Nf1 to Sdhb knockout: Successes and failures in the quest for animal models of pheochromocytoma.
    Lepoutre-Lussey C; Thibault C; Buffet A; Morin A; Badoual C; Bénit P; Rustin P; Ottolenghi C; Janin M; Castro-Vega LJ; Trapman J; Gimenez-Roqueplo AP; Favier J
    Mol Cell Endocrinol; 2016 Feb; 421():40-8. PubMed ID: 26123588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pediatric Metastatic Pheochromocytoma and Paraganglioma: Clinical Presentation and Diagnosis, Genetics, and Therapeutic Approaches.
    Kuo MJM; Nazari MA; Jha A; Pacak K
    Front Endocrinol (Lausanne); 2022; 13():936178. PubMed ID: 35903274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas.
    Garcia-Carbonero R; Matute Teresa F; Mercader-Cidoncha E; Mitjavila-Casanovas M; Robledo M; Tena I; Alvarez-Escola C; Arístegui M; Bella-Cueto MR; Ferrer-Albiach C; Hanzu FA
    Clin Transl Oncol; 2021 Oct; 23(10):1995-2019. PubMed ID: 33959901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic and Clinical Profiles of Pheochromocytoma and Paraganglioma: A Single Center Study.
    Ma X; Li M; Tong A; Wang F; Cui Y; Zhang X; Zhang Y; Chen S; Li Y
    Front Endocrinol (Lausanne); 2020; 11():574662. PubMed ID: 33362715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic stratification of inherited and sporadic phaeochromocytoma and paraganglioma: implications for precision medicine.
    Casey R; Neumann HPH; Maher ER
    Hum Mol Genet; 2020 Oct; 29(R2):R128-R137. PubMed ID: 33059362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The utility of SDHB and FH immunohistochemistry in patients evaluated for hereditary paraganglioma-pheochromocytoma syndromes.
    Udager AM; Magers MJ; Goerke DM; Vinco ML; Siddiqui J; Cao X; Lucas DR; Myers JL; Chinnaiyan AM; McHugh JB; Giordano TJ; Else T; Mehra R
    Hum Pathol; 2018 Jan; 71():47-54. PubMed ID: 29079178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Personalized Management of Pheochromocytoma and Paraganglioma.
    Nölting S; Bechmann N; Taieb D; Beuschlein F; Fassnacht M; Kroiss M; Eisenhofer G; Grossman A; Pacak K
    Endocr Rev; 2022 Mar; 43(2):199-239. PubMed ID: 34147030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptome Analysis of lncRNAs in Pheochromocytomas and Paragangliomas.
    Job S; Georges A; Burnichon N; Buffet A; Amar L; Bertherat J; Bouatia-Naji N; de Reyniès A; Drui D; Lussey-Lepoutre C; Favier J; Gimenez-Roqueplo AP; Castro-Vega LJ
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31678991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metastatic sympathetic paraganglioma in a patient with loss of the SDHC gene.
    Rich T; Jackson M; Roman-Gonzalez A; Shah K; Cote GJ; Jimenez C
    Fam Cancer; 2015 Dec; 14(4):615-9. PubMed ID: 26162468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GIPC2 is an endocrine-specific tumor suppressor gene for both sporadic and hereditary tumors of RET- and SDHB-, but not VHL-associated clusters of pheochromocytoma/paraganglioma.
    Dong Y; Huang Y; Fan C; Wang L; Zhang R; Li W; Guo Z; Wang D; Zheng Z
    Cell Death Dis; 2021 May; 12(5):444. PubMed ID: 33947839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pathologist contribution in the diagnosis of hereditary predisposition to paranganglioma and pheochromocytoma].
    Broudin C; Favier J; Verkarre V; Méatchi T
    Ann Pathol; 2020 Apr; 40(2):134-141. PubMed ID: 32146049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis and Management of Hereditary Phaeochromocytoma and Paraganglioma.
    Lalloo F
    Recent Results Cancer Res; 2016; 205():105-24. PubMed ID: 27075351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.